10x Genomics (TXG) News Today → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free TXG Stock Alerts $26.39 -0.17 (-0.64%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 8:04 AM | marketbeat.comJump Financial LLC Decreases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Jump Financial LLC lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 56.9% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 31,803 shares of the company's stock after selling 42,052 shares during the period. Jump Financial LLC'sMay 14 at 5:41 AM | finance.yahoo.comCathie Wood’s Latest Buys: 3 Stocks the ARK Invest CEO Can’t Get Enough OfMay 6, 2024 | investorplace.comCathie Wood's Latest Buys: 3 Stocks the ARK Invest CEO Can't Get Enough OfMay 4, 2024 | marketbeat.comVestmark Advisory Solutions Inc. Makes New $4.33 Million Investment in 10x Genomics, Inc. (NASDAQ:TXG)Vestmark Advisory Solutions Inc. bought a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 77,409 shares of the company's stock, valued at approximately $4,332,000. VeMay 3, 2024 | marketbeat.comQ2 2024 Earnings Estimate for 10x Genomics, Inc. Issued By William Blair (NASDAQ:TXG)10x Genomics, Inc. (NASDAQ:TXG - Free Report) - William Blair lifted their Q2 2024 EPS estimates for 10x Genomics in a note issued to investors on Wednesday, May 1st. William Blair analyst M. Larew now anticipates that the company will post earnings per share of ($0.53) for the quarter, up from tMay 2, 2024 | prnewswire.com10x Genomics to Present at the BofA Securities 2024 Healthcare ConferenceMay 2, 2024 | msn.comTD Cowen Downgrades 10x Genomics (TXG)May 2, 2024 | finance.yahoo.com10x Genomics First Quarter 2024 Earnings: In Line With ExpectationsMay 2, 2024 | finanznachrichten.de10x Genomics, Inc: 10x Genomics Reports First Quarter 2024 Financial ResultsMay 1, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Given New $30.00 Price Target at UBS GroupUBS Group lowered their target price on shares of 10x Genomics from $52.00 to $30.00 and set a "neutral" rating on the stock in a research report on Wednesday.May 1, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Hits New 12-Month Low After Analyst Downgrade10x Genomics (NASDAQ:TXG) Reaches New 1-Year Low After Analyst DowngradeMay 1, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)May 1, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Downgraded by TD CowenTD Cowen downgraded 10x Genomics from a "buy" rating to a "hold" rating and dropped their price objective for the company from $57.00 to $32.00 in a research note on Wednesday.May 1, 2024 | finance.yahoo.com10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ...May 1, 2024 | businesswire.comCurio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)April 30, 2024 | sfgate.com10x Genomics: Q1 Earnings SnapshotApril 30, 2024 | markets.businessinsider.comTXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024April 30, 2024 | finance.yahoo.com10x Genomics Inc (TXG) Q1 2024 Earnings: Misses Analyst Expectations Amidst New Product LaunchesApril 30, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Releases Earnings Results, Misses Estimates By $0.04 EPS10x Genomics (NASDAQ:TXG - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.46) by ($0.04). 10x Genomics had a negative return on equity of 28.82% and a negative net margin of 41.17%. The company had revenue of $141.01 million for the quarter, compared to analyst estimates of $142.24 million. During the same period in the previous year, the firm posted ($0.44) earnings per share. The firm's quarterly revenue was up 5.0% compared to the same quarter last year.April 30, 2024 | prnewswire.com10x Genomics Reports First Quarter 2024 Financial ResultsApril 29, 2024 | markets.businessinsider.com10x Genomics A is about to announce its earnings — here's what Wall Street expectsApril 29, 2024 | marketbeat.comCanaccord Genuity Group Cuts 10x Genomics (NASDAQ:TXG) Price Target to $50.00Canaccord Genuity Group dropped their price target on 10x Genomics from $65.00 to $50.00 and set a "buy" rating on the stock in a research report on Monday.April 29, 2024 | finance.yahoo.comThe Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorpApril 25, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Sets New 52-Week Low at $26.4810x Genomics (NASDAQ:TXG) Reaches New 52-Week Low at $26.48April 23, 2024 | marketbeat.com10x Genomics (TXG) to Release Earnings on Tuesday10x Genomics (NASDAQ:TXG) will be releasing earnings after the market closes on Tuesday, April 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=583445)April 21, 2024 | nasdaq.comFirst Week of TXG June 21st Options TradingApril 18, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Shares Gap Down Following Analyst Downgrade10x Genomics (NASDAQ:TXG) Shares Gap Down Following Analyst DowngradeApril 17, 2024 | finance.yahoo.com10x Genomics, Inc. (TXG)April 16, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Trading Down 5.9%10x Genomics (NASDAQ:TXG) Trading Down 5.9%April 16, 2024 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Sumitomo Mitsui Trust Holdings Inc.Sumitomo Mitsui Trust Holdings Inc. grew its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 32.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,283,530 shares of the company's stock after purchasing anApril 15, 2024 | marketbeat.comSVB Wealth LLC Has $80.95 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)SVB Wealth LLC lifted its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 92.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,446,552 shares of the company's stock after acquiriApril 15, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Hits New 52-Week Low at $33.4710x Genomics (NASDAQ:TXG) Sets New 52-Week Low at $33.47April 11, 2024 | investing.comCathie Wood's ARK focuses on Teladoc and 10X Genomics stockApril 10, 2024 | finance.yahoo.com10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024April 10, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Price Target Cut to $45.00Barclays cut their target price on shares of 10x Genomics from $55.00 to $45.00 and set an "overweight" rating for the company in a research note on Wednesday.April 10, 2024 | prnewswire.com10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024April 10, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Shares Gap Down to $37.3710x Genomics (NASDAQ:TXG) Shares Gap Down to $37.37April 9, 2024 | marketbeat.comBaillie Gifford & Co. Decreases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Baillie Gifford & Co. lowered its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 5.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,919,976 shares of the company's stock after selling 420,92March 28, 2024 | marketbeat.comARK Investment Management LLC Acquires 1,047,827 Shares of 10x Genomics, Inc. (NASDAQ:TXG)ARK Investment Management LLC boosted its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 35.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,041,287 shares of the company's stock after acquiriMarch 27, 2024 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Acquired by Vanguard Group Inc.Vanguard Group Inc. lifted its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 4.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,903,517 shares of the company's stock after buyingMarch 26, 2024 | finance.yahoo.com10x Genomics Commercially Launches Visium HD Spatial Gene Expression AssayMarch 23, 2024 | finanznachrichten.de10x Genomics, Inc: 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene PanelMarch 21, 2024 | finance.yahoo.com10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene PanelMarch 16, 2024 | ca.finance.yahoo.comTXG Nov 2024 40.000 putMarch 16, 2024 | ca.finance.yahoo.comTXG Aug 2024 60.000 callMarch 16, 2024 | ca.finance.yahoo.comTXG Dec 2024 40.000 putMarch 16, 2024 | insidertrades.comInsider Selling: 10x Genomics, Inc. (NASDAQ:TXG) CEO Sells 4,660 Shares of StockMarch 16, 2024 | finance.yahoo.comTXG Apr 2024 60.000 callMarch 16, 2024 | finance.yahoo.comTXG Apr 2024 40.000 putMarch 14, 2024 | finanznachrichten.de10x Genomics, Inc: 10x Genomics Begins Commercial Shipments of Chromium GEM-X Products Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. TXG Media Mentions By Week TXG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXG News Sentiment▼0.900.54▲Average Medical News Sentiment TXG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXG Articles This Week▼54▲TXG Articles Average Week Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Olink Holding AB (publ) News Cytek Biosciences News Bio-Rad Laboratories News Bio-Rad Laboratories News IDEAYA Biosciences News Amedisys News Sotera Health News iRhythm Technologies News SpringWorks Therapeutics News Xenon Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TXG) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsDoes this make you sick?Allegiance Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
